Literature DB >> 759736

Clinical spectrum of Wilson's disease (hepatolenticular degeneration).

W B Dobyns, N P Goldstein, H Gordon.   

Abstract

Fifty-eight patients with Wilson's disease are reviewed, of whom 25 symptomatic patients experienced liver disease first and 28, brain disease. Ten of these patients presented with liver disease alone, 19 with brain disease alone, and 24 with evidence of both liver and brain disease. The remaining five were discovered as asymptomatic siblings of known patients. Three of the patients with hepatic presentation and one with neurologic presentation later experienced the other type of symptomatology, bringing the total number of patients with mixed disease to 28. Of the 44 patients with brain disease, 12 presented primarily with extrapyramidal findings, 6 with cerebellar findings, and 17 with both; pseudobulbar findings were noted in 9 patients, all of whom had other symptoms of severe nervous system disease. In addition to these presentations, in an appreciable number of patients the first symptoms were of a mental or emotional disorder. Disease of other organ systems, such as the joints and kidneys, also occurred but infrequently. Where adequate family information was available, 13 of 65 siblings (20%) were known to have had or were suspected of having had Wilson's disease. This is consistent with the autosomal-recessive pattern of inheritance.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 759736

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  13 in total

1.  Wilson's disease in adults with cirrhosis but no neurological abnormalities.

Authors:  D M Danks; G Metz; R Sewell; E J Prewett
Journal:  BMJ       Date:  1990-08-11

2.  Haemolytic anaemia as initial manifestation of Wilson's disease.

Authors:  H Lehr; M Pauschinger; E Pittke; E Kurrle; H Heimpel
Journal:  Blut       Date:  1988-01

3.  The Kayser-Fleischer ring during long-term treatment in Wilson's disease (hepatolenticular degeneration). A follow-up study.

Authors:  A Lössner; J Lössner; H Bachmann; J Zotter
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1986       Impact factor: 3.117

4.  D-penicillamine in Wilson's disease presenting as acute liver failure with hemolysis.

Authors:  W Vielhauer; V Eckardt; K H Holtermüller; J B Lüth; B Schulte; W Prellwitz; W Sonntag
Journal:  Dig Dis Sci       Date:  1982-12       Impact factor: 3.199

5.  The psychiatric aspects of wilson's disease-a study from a neurology unit.

Authors:  R Kumar; S Datta; L Jayaseelan; C Gnanmuthu; K Kuruvilla
Journal:  Indian J Psychiatry       Date:  1996-10       Impact factor: 1.759

6.  Presenting symptoms and natural history of Wilson disease.

Authors:  T Saito
Journal:  Eur J Pediatr       Date:  1987-05       Impact factor: 3.183

7.  Copper(II)-catalyzed lipid peroxidation in liposomes and erythrocyte membranes.

Authors:  P C Chan; O G Peller; L Kesner
Journal:  Lipids       Date:  1982-05       Impact factor: 1.880

8.  Neurological and neuropsychiatric spectrum of Wilson's disease: a prospective study of 45 cases.

Authors:  W Oder; G Grimm; H Kollegger; P Ferenci; B Schneider; L Deecke
Journal:  J Neurol       Date:  1991-08       Impact factor: 4.849

9.  Relationship between striatal glucose consumption and copper excretion in patients with Wilson's disease treated with D-penicillamine.

Authors:  H Hefter; T Kuwert; H Herzog; G Arendt; W Stremmel; L E Feinendegen
Journal:  J Neurol       Date:  1993-11       Impact factor: 4.849

10.  Wilson's disease. Clinical correction with cranial computed tomography.

Authors:  B E Kendall; S S Pollock; N M Bass; A R Valentine
Journal:  Neuroradiology       Date:  1981       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.